IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avoro Capital Advisors LLC

Portfolio Profile

CIK: 0001633313 | NEW YORK, NY

Investment Profile

Style

Aggressive Growth

Turnover

Medium

Orientation

Concentrated trader
$11.1B
AUM
26
Positions
79.46%
Top 10 Conc.
99.94%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1United Therapeutics Corp(UTHR)2,777,777$1.5B13.52%
2Ascendis Pharma(ASND)5,111,111$1.4B12.24%
3Krystal Biotech Inc(KRYS)2,888,888$1.1B9.64%
4Madrigal Pharmaceuticals Inc(MDGL)1,833,333$984.4M8.84%
5Argenx SE(ARGX)1,000,000$927.8M8.33%
6

Sector Allocation

Latest filing, equity positions only

Healthcare96.15% · $10.7B
Unclassified3.85% · $429.0M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.79%96.15%-2.64%
Unclassified1.21%3.85%+2.64%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$6.4B | 46 pos.
$7.2B | 42 pos.
$8.6B | 46 pos.
$7.5B | 41 pos.
$6.9B | 36 pos.
$7.1B | 39 pos.
Arrowhead Pharmaceuticals Inc(ARWR)
11,355,555
$925.6M
8.31%
7Kymera Therapeutics Inc(KYMR)7,474,747$857.1M7.70%
8Revolution Medicines Inc(RVMD)2,297,000$430.2M3.86%
9Cytokinetics Inc(CYTK)4,999,999$425.9M3.82%
10Celcuity Inc(CELC)3,400,000$355.7M3.19%
Cap SizePrev %Curr %Change
Large Cap45.58%46.79%+1.21%
Mid Cap48.72%44.61%-4.11%
Small Cap4.18%3.91%-0.27%
Unclassified1.21%3.85%+2.64%
Micro Cap0.3%0.83%+0.53%
$6.4B | 33 pos.
$5.7B | 30 pos.
$7.7B | 32 pos.
$10.2B | 34 pos.
$10.2B | 33 pos.
$11.1B | 26 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
9
Closed
11
Increased
3
Decreased
9
Unchanged